PATENT CLAIM ANALYSIS

Application Number: 15882924
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "252160"]

Abstract:
The present invention relates to pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment and/or prevention of a proliferation disorder, a cancer, a tumor, an inflammatory disease, an autoimmune disease, psoriasis, dry eye or an immunologically related disease, and in some embodiments diseases or disorders related to the dysregulation of kinase such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, FLT3(D835Y), ITK, TEC, TXK, BTK, or JAK, and the respective pathways.

Claim (Index 15):
A method for treating and/or preventing a proliferation disorder, a cancer, a tumor, an inflammatory disease, an autoimmune disease, psoriasis, dry eye or an immunologically related disease, or lupus, which comprises administering to a subject in need thereof an effective amount of a compound of  claim 3 .

Metadata:
- Claim Count in Document: 66.0
- Percentile: 86.0
- Lexical Diversity: 1.68182
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14329890', '16068559', '13436910', '14712794', '13436963']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7834721397080703
- 35 USC 102 Novelty (BERT): 0.5475298086991054
- Combined Prediction Score: 0.7598779066071738
- Mean Citation Score: 306.409536
- Max Citation Score: 426.96307
- Similarity Product: 260.82949347835245

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test